Levels of expression of CD19 and CD20 in chronic B cell leukaemias.
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
AIMS: To investigate whether the antigen levels of the B cell lineage markers CD19 and CD20 can distinguish between normal and neoplastic B cells or characterise distinct expression patterns among the chronic B cell leukaemias. METHODS: Peripheral blood cells from 70 patients with B cell disorders and 17 healthy donors were analysed by quantitative flow cytometry. Direct immunofluorescence staining was performed with phycoerythrin conjugated CD19 and CD20 monoclonal antibodies. Standard microbeads with different capacities to bind mouse immunoglobulins were used to convert the mean fluorescence intensity (MFI) values into number of antigen molecules/cell, expressed as antibody binding capacity (ABC). RESULTS: CD19 and CD20 ABC values in leukaemic B cells differed from those of normal blood B lymphocytes. The results identified distinct profiles of CD19 and CD20 expression in the various types of B cell leukaemias. In all leukaemias studied except hairy cell leukaemia (HCL), CD19 expression was significantly lower than the mean (SD) value in normal B cells (22 (7) x 10(3) molecules/cell), as follows: chronic lymphocytic leukaemia (CLL), 13 (7) x 10(3); B prolymphocytic leukaemia (B-PLL), 16 (9) x 10(3); splenic lymphoma with villous lymphocytes (SLVL), 15 (11) x 10(3); mantle cell lymphoma (MCL), 10 (7) x 10(3). In HCL there was strong CD19 expression (38 (16) x 10(3)). In contrast, the level of expression of membrane CD20 was higher than the mean (SD) value in normal B cells (94 (16) x 10(3) molecules/cell) in MCL (123 (51) x 10(3)); B-PLL (129 (47) x 10(3)); SLVL (167 (72) x 10(3)); and HCL (312 (110) x 10(3)); while it was significantly lower (65 (11) x 10(3)) in CLL compared with normal B cells and the other B cell leukaemias. CONCLUSIONS: Quantitative determination of CD19 and CD20 may provide useful diagnostic information for the study of B lymphoproliferative disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matutes, E., Owusu-Ankomah, K. A., Morilla, R. M., García Marco, J., Houlihan, A., Que, T., & Catovsky, D. (1994) · PubMed · Cited by 779
Self-citationBennett, J. M., Catovsky, D., Daniel, M. T., Flandrin, G., Galton, D. A., Gralnick, H. R., & Sultan, C. (1989) · Journal of Clinical Pathology · doi:10.1136/jcp.42.6.567 · Cited by 694
Self-citationFlow cytometric analysis of human bone marrow. II. Normal B lymphocyte development
Loken, M., Shah, V., Dattilio, K., & Civin, C. (1987) · Blood · doi:10.1182/blood.v70.5.1316.1316 · Cited by 442
CD19 Antigen in Leukemia and Lymphoma Diagnosis and Immunotherapy
Scheuermann, R. H., & Racila, E. (1995) · Leukemia & Lymphoma · doi:10.3109/10428199509059636 · Cited by 323
The B cell surface molecule B1 is functionally linked with B cell activation and differentiation.
Tedder, T. F., Boyd, A. W., Freedman, A. S., Nadler, L. M., & Schlossman, S. F. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.2.973 · Cited by 226
Rothe, G., & Schmitz, G. (1996) · PubMed · Cited by 221
Matutes, E., Morilla, R. M., Owusu-Ankomah, K. A., Houliham, A., Meeus, M., & Catovsky, D. (1994) · PubMed · Cited by 183
Self-citationPhosphorylation of the CD20 Phosphoprotein in Resting B Lymphocytes
Valentine, M. A., Meier, K. E., Rossie, S. S., & Clark, E. A. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60461-2 · Cited by 95
Kanzaki, M., Shibata, H., Mogami, H., & Kojima, I. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.13099 · Cited by 95
Lenkei, R., & Andersson, B. (1995) · Journal of Immunological Methods · doi:10.1016/0022-1759(95)00064-h · Cited by 75
Ginaldi, L., Farahat, N. M. G., Matutes, E., Martinis, M. D., Morilla, R. M., & Catovsky, D. (1996) · Journal of Clinical Pathology · doi:10.1136/jcp.49.7.539 · Cited by 65
Self-citationTefferi, A., Bartholmai, B. J., Witzig, T. E., Li, C., Hanson, C. A., & Phyliky, R. L. (1996) · American Journal of Clinical Pathology · doi:10.1093/ajcp/106.4.457 · Cited by 39
Cited by
Hallek, M., Cheson, B. D., Catovsky, D., Caligaris-Cappio, F., Dighiero, G., Döhner, H., Hillmen, P., Keating, M. J., Montserrat, E., Rai, K. R., et al. (2008) · Blood · doi:10.1182/blood-2007-06-093906 · Cited by 3,787
Self-citationHallek, M., Cheson, B. D., Catovsky, D., Caligaris-Cappio, F., Dighiero, G., Döhner, H., Hillmen, P., Keating, M., Montserrat, E., Chiorazzi, N., et al. (2018) · Blood · doi:10.1182/blood-2017-09-806398 · Cited by 1,740
Self-citationCD19: a biomarker for B cell development, lymphoma diagnosis and therapy
Wang, K., Wei, G., & Liu, D. (2012) · Experimental Hematology & Oncology · doi:10.1186/2162-3619-1-36 · Cited by 562
Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment
Hallek, M. (2019) · American Journal of Hematology · doi:10.1002/ajh.25595 · Cited by 504
Golay, J., Lazzari, M., Facchinetti, V., Bernasconi, S., Borleri, G., Barbui, T., Rambaldi, A., & Introna, M. (2001) · Blood · doi:10.1182/blood.v98.12.3383 · Cited by 428
Metadata
- Authors
- Ginaldi, L., De Martinis, M., Matutes, E., Farahat, N., Morilla, R., & Catovsky, D.
- Venue
- Journal of Clinical Pathology
- Publisher
- BMJ
- Published
- 1998-05
- Volume
- 51
- Issue
- 5
- Pages
- 364-369
- ISSN
- 0021-9746 (ISSN-L)
- 1472-4146
- OpenAlex
- W2132433919
- Cited by
- 325
- References
- 12
- FWCI
- 4.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.